{
  "trial_id": "NCT03213002",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Be capable of giving informed consent.",
      "label": "met",
      "evidence": "Patient text does not mention any issues with informed consent."
    },
    {
      "criterion": "Have a pathology proven diagnosis of any of newly diagnosed Glioblastoma Multiforme",
      "label": "not_met",
      "evidence": "Patient has anaplastic astrocytoma, not glioblastoma multiforme."
    },
    {
      "criterion": "WHO IV",
      "label": "unknown",
      "evidence": "No mention of WHO classification in patient text."
    },
    {
      "criterion": "Have completed the first part of standard of care chemo-radiation (Stupp), for 6 weeks, and not started the maintenance phase of temozolomide",
      "label": "unknown",
      "evidence": "Patient received radiation followed by temozolomide, but duration is unclear."
    },
    {
      "criterion": "Agree to use effective barrier contraception while on treatment and for 2 months thereafter, if of childbearing potential",
      "label": "unknown",
      "evidence": "No mention of patient's reproductive status or plans in patient text."
    },
    {
      "criterion": "Have a life expectancy > 3 months",
      "label": "met",
      "evidence": "Patient has unresectable anaplastic astrocytoma, but no clear indication of limited life expectancy."
    },
    {
      "criterion": "Be between the ages of 18 to 74",
      "label": "met",
      "evidence": "Patient is 45 years old, within the specified age range."
    },
    {
      "criterion": "Have a performance status KPS 70 or greater",
      "label": "unknown",
      "evidence": "No mention of patient's performance status in patient text."
    },
    {
      "criterion": "Be able to swallow pills and capsules",
      "label": "met",
      "evidence": "Patient is described as having severe lower extremity weakness, but no indication of difficulty swallowing."
    },
    {
      "criterion": "Be able to tolerate oral chemotherapeutic medications, with no health threatening allergies or side effects, based on lab and clinical findings",
      "label": "unknown",
      "evidence": "Patient has chronic pain and hypertension, but no clear indication of intolerance to oral chemotherapy."
    },
    {
      "criterion": "Have adequate bone marrow function, liver function and renal function before commencing therapy",
      "label": "unknown",
      "evidence": "No mention of patient's laboratory values in patient text."
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior chemotherapy with capecitabine or temozolomide for other prior malignancies.",
      "label": "met",
      "evidence": "Patient received temozolomide during radiation, but this is allowed per trial criteria."
    },
    {
      "criterion": "Patients previously treated with continuous infusion 5-FU or any schedule of DTIC, which are similar to capecitabine and temozolomide, respectively, will be excluded.",
      "label": "unknown",
      "evidence": "No mention of patient's prior chemotherapy regimens in patient text."
    },
    {
      "criterion": "Prior chemotherapies for newly diagnosed GBM or AA, other than temozolomide during radiation.",
      "label": "met",
      "evidence": "Patient received temozolomide during radiation, which is allowed per trial criteria."
    },
    {
      "criterion": "Patients with a history of severe hypersensitivity reaction to capecitabine, 5-FU, temozolomide (i.e. anaphylaxis or anaphylactic reactions),",
      "label": "unknown",
      "evidence": "No mention of patient's prior hypersensitivity reactions in patient text."
    },
    {
      "criterion": "Serious medical or psychiatric illness preventing informed consent or treatment (e.g., serious infection)",
      "label": "unknown",
      "evidence": "Patient has chronic pain and hypertension, but no clear indication of a serious medical or psychiatric illness."
    },
    {
      "criterion": "Prior malignancies in the last 5 years other than curatively treated carcinoma in-situ previously treated with curative intent (cancer free for the past one year).",
      "label": "unknown",
      "evidence": "No mention of patient's prior malignancies in patient text."
    },
    {
      "criterion": "Performance status, KPS < 70",
      "label": "unknown",
      "evidence": "No mention of patient's performance status in patient text."
    },
    {
      "criterion": "Inability to swallow pills and capsules",
      "label": "met",
      "evidence": "Patient is described as having severe lower extremity weakness, but no indication of difficulty swallowing."
    }
  ],
  "notes": "Key unknowns include patient's WHO classification, performance status, and laboratory values. Additionally, the duration of standard of care chemo-radiation completed by the patient is unclear.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT03213002",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b"
  }
}